| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.087 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |